About Doctor Kamalian:
MD, MMSc
Harvard Business School

He specializes in value proposition refinement, and commercialization planning, helping founders position their ventures for success in today’s complex healthcare ecosystem.

Shervin earned his medical degree in 2009 and went on to complete both research and clinical neuroradiology fellowships at Massachusetts General Hospital, where he co authored over 20 peer reviewed publications, along with numerous abstracts and book chapters. During this time, he was awarded a prestigious scholarship to Harvard Medical School, where he earned a Master’s in Clinical Investigation with a focus on translational research. His turning point came at Harvard Business School through the highly regarded Commercializing Science program. There, Shervin participated in the development and delivery of sophisticated commercialization strategies for breakthrough medical technologies and therapeutics, culminating in high stakes presentations to potential investors, Harvard Business School faculty, and industry stakeholders. This experience solidified his passion for translating cutting edge innovation into scalable, investable solutions.

Today, alongside his ongoing clinical work in the radiologic evaluation of complex cancer cases—particularly those involving the central nervous system and head and neck—Shervin serves as a trusted strategic advisor to healthcare startups.